Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats
Hanna E. Kastman, Anna Błasiak, Leigh C. Walker, et al.
Neuropharmacology (2016) Vol. 110, pp. 82-91
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
Dual-transmitter systems regulating arousal, attention, learning and memory
Sherie Ma, Balázs Hangya, Christopher S. Leonard, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 85, pp. 21-33
Open Access | Times Cited: 106
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102
Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86
Distribution, physiology and pharmacology of relaxin‐3/RXFP3 systems in brain
Sherie Ma, Craig M. Smith, Anna Błasiak, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 10, pp. 1034-1048
Open Access | Times Cited: 77
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Early-life adversity alters adult nucleus incertus neurons: implications for neuronal mechanisms of increased stress and compulsive behavior vulnerability
Anna Guguła, Patryk Sambak, Aleksandra Trenk, et al.
Neuropsychopharmacology (2025)
Open Access
The Role of Orexins/Hypocretins in Alcohol Use and Abuse
Leigh C. Walker, Andrew J. Lawrence
Current topics in behavioral neurosciences (2016), pp. 221-246
Open Access | Times Cited: 42
A balancing act: the role of pro‐ and anti‐stress peptides within the central amygdala in anxiety and alcohol use disorders
Leigh C. Walker
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1615-1643
Open Access | Times Cited: 29
Acute orexin antagonism selectively modulates anticipatory anxiety in humans: implications for addiction and anxiety
Stephanie M. Gorka, Kia J. Khorrami, Charles A. Manzler, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior
Alan Kania, Agata Szlaga, Patryk Sambak, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 28, pp. 5362-5375
Open Access | Times Cited: 29
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Orexin A in adolescents with anxiety disorders
Ömer Faruk Akça, Necati Uzun, İbrahim Kılınç
International Journal of Psychiatry in Clinical Practice (2020) Vol. 24, Iss. 2, pp. 127-134
Closed Access | Times Cited: 28
Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
Francisco J. Flores‐Ramirez, Jessica M. Illenberger, Glenn Pascasio, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 16
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control
Anna Błasiak, Andrew L. Gundlach, Grzegorz Hess, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 30
Central amygdala relaxin‐3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats
Leigh C. Walker, Hanna E. Kastman, Elena Krstew, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3359-3369
Open Access | Times Cited: 30
Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
Mark K. Greenwald
Neurobiology of Stress (2018) Vol. 9, pp. 84-104
Open Access | Times Cited: 29
Cocaine and amphetamine regulated transcript (CART) signalling in the central nucleus of the amygdala modulates stress-induced alcohol seeking
Leigh C. Walker, Lexi J. Hand, Bethany Letherby, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 2, pp. 325-333
Open Access | Times Cited: 25
Muscarinic M4 and M5 receptors in the ventral subiculum differentially modulate alcohol seeking versus consumption in male alcohol‐preferring rats
Leigh C. Walker, Kate L. Huckstep, Nicola A. Chen, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 18, pp. 3730-3746
Open Access | Times Cited: 20
Modulation of forebrain function by nucleus incertus and relaxin‐3/RXFP3 signaling
Francisco E. Olucha‐Bordonau, Héctor Albert‐Gascó, Francisco Ros‐Bernal, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 8, pp. 694-702
Open Access | Times Cited: 26
Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial
Erin J. Campbell, Amanda Norman, Yvonne Bonomo, et al.
Brain Research (2019) Vol. 1728, pp. 146597-146597
Closed Access | Times Cited: 24
Unveiling a novel memory center in human brain: neurochemical identification of the nucleus incertus, a key pontine locus implicated in stress and neuropathology
Camila de Ávila, Anna Guguła, Aleksandra Trenk, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 2
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
David E. Moorman
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1663-1680
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top